Co‐detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease‐2019 pneumonia
María Luisa Blasco, Javier Buesa, Javier Colomina, María José Forner, María José Galindo, Jorge Navarro, José Noceda, Josep Redón, Jaime Signes‐Costa, David Navarro
Abstract
To the Editor, Clinical, laboratory, and imaging characteristics of Coronavirus disease 2019 (COVID-19), and risk factors associated with poor outcomes have been reported in various studies. Nevertheless, information on whether other respiratory pathogens (RP) were codetected in patients in these series was not provided, despite the fact that coinfections with RP have been reported to occur in this clinical setting. 3-6 Documentation of coinfections in COVID-19 pneumonia patients may be relevant not only for appropriate clinical and therapeutic management of patients but also to precisely characterize disease features and delineate risk factors potentially impacting on clinical outcomes. Here, we report on our experience on this topic, gathered between 4th March and 28th March 2020, at the Clinic University Hospital of Valencia, a tertiary teaching hospital with 586 beds which serves Clnico-Malvarrosa Health Department (attending 368.000 inhabitants in the northeast of the city).